The Labour party has today announced its new life sciences sector plan, aimed at transforming the discovery and delivery of medical treatments. The strategy will promote innovation in the NHS, and seeks to increase R&D investment in the pharmaceutical sector by £10bn per year.
On the announcement, Prof Siddharthan Chandran, Director of the UK DRI, said:
“This is an ambitious, forward-thinking strategy from Labour that demonstrates a strong commitment to realising the UK’s potential as a global leader in life sciences. By harnessing the UK’s strengths, including in discovery science, data, and the research capacity of our NHS, we will attract investment to the UK and deliver much-needed new treatments to patients faster.
“The UK is already conducting pioneering research to find new treatments for dementia and neurodegenerative diseases. With the scientific field on the cusp of major breakthroughs, now is the time to forge ahead and ensure the UK is at the vanguard of global progress – to benefit our economy and our health.
“As a national institute funded by the MRC, the UK Dementia Research Institute is poised to collaborate to achieve this vision.”
Article published: 30 January 2024
Banner image: Copyright UK DRI Ltd
